Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/5980
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuziba, Nathan-
dc.date.accessioned2022-02-16T06:34:53Z-
dc.date.available2022-02-16T06:34:53Z-
dc.date.issued2018-
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/29946526/-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/5980-
dc.description.abstractuberculosis (TB) is a leading cause of childhood mortality. Isoniazid preventive therapy significantly reduces progression to TB disease. The World Health Organization recommends that high TB burden countries conduct child contact management (CCM) to identify exposed child contacts aged <5 years for screening and appropriate treatment. An active, clinic-based CCM strategy incorporating transport/screening reimbursement, monitoring and evaluation tools, and health care worker education was implemented in western Kenya. Among 169 identified child contacts aged <5 years, 146 (86%) underwent successful screening, of whom 43 (29%) were diagnosed with active TB. We describe our CCM strategy and its potential for enhancing screening and treatment efforts.en_US
dc.language.isoenen_US
dc.publisherPubMeden_US
dc.subjectChild contact managementen_US
dc.subjectIsoniazid preventive therapyen_US
dc.subjectPediatric TBen_US
dc.titleImplementation of an active, clinic-based child tuberculosis contact management strategy in western Kenyaen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.